Chickadee Biomedicines, Inc.
Biotechnology · BOSTON, MA
BiotechnologySEC Form D
Chickadee Biomedicines, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 25, 2026, reporting $150,000 raised toward a $1,000,000 offering.
Incorporated in Delaware and based in BOSTON, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Chickadee Biomedicines, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Weining LuExecutive Officer · Director · Promoter
- Mikael Goran DolstenExecutive Officer · Director · Promoter
Recently funded in Biotechnology
Other companies that recently filed a Form D
$19.1MRaised
Rapalogix Health, Inc.
$500.0KRaised
Boston Interactome, Inc.
$3.8MRaised
DINYA DNA, Inc.
$6.5MRaised
REGENTIS BIOMATERIALS LTD.
$16.5MRaised